TI
NVCR icon

Trexquant Investment’s NovoCure NVCR Stock Holding History

Trexquant Investment’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.52M Buy
+166,278
New +$2.52M 0.01% 1094
2025
Q4 		– Sell
-69,148
Closed -$893K – 1827
2025
Q3 		$893K Buy
+69,148
New +$924K 0.01% 1181
2024
Q4 		– Sell
-113,849
Closed -$1.78M – 1764
2024
Q3 		$1.78M Sell
113,849
-72,087
-39% -$1.31M 0.02% 852
2024
Q2 		$3.19M Sell
185,936
-92,402
-33% -$1.63M 0.05% 556
2024
Q1 		$4.35M Buy
278,338
+52,018
+23% +$765K 0.09% 354
2023
Q4 		$3.38M Buy
226,320
+159,755
+240% +$2.14M 0.08% 379
2023
Q3 		$1.08M Buy
+66,565
New +$1.92M 0.03% 725
2023
Q2 		– Sell
-3,986
Closed -$240K – 1685
2023
Q1 		$240K Sell
3,986
-272
-6% -$21.7K 0.01% 1270
2022
Q4 		$312K Buy
+4,258
New +$320K 0.01% 1087
2022
Q2 		– Sell
-6,840
Closed -$567K – 1751
2022
Q1 		$567K Sell
6,840
-23,011
-77% -$1.7M 0.03% 711
2021
Q4 		$2.24M Buy
29,851
+16,763
+128% +$1.68M 0.14% 184
2021
Q3 		$1.52M Buy
+13,088
New +$1.98M 0.12% 237
2021
Q2 		– Sell
-13,683
Closed -$1.81M – 1373
2021
Q1 		$1.81M Buy
+13,683
New +$2.16M 0.17% 163
2020
Q4 		– Sell
-15,147
Closed -$1.69M – 1355
2020
Q3 		$1.69M Sell
15,147
-5,905
-28% -$472K 0.11% 263
2020
Q2 		$1.25M Buy
21,052
+9,554
+83% +$628K 0.09% 331
2020
Q1 		$774K Buy
+11,498
New +$909K 0.06% 497
2019
Q4 		– Sell
-24,067
Closed -$1.8M – 1203
2019
Q3 		$1.8M Buy
+24,067
New +$1.92M 0.16% 183
2019
Q2 		– Sell
-32,438
Closed -$1.56M – 1024
2019
Q1 		$1.56M Buy
32,438
+25,310
+355% +$1.22M 0.11% 271
2018
Q4 		$239K Buy
+7,128
New +$261K 0.01% 855
2018
Q1 		– Sell
-25,648
Closed -$518K – 1287
2017
Q4 		$518K Buy
25,648
+14,958
+140% +$288K 0.06% 497
2017
Q3 		$212K Buy
+10,690
New +$210K 0.05% 610

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Trexquant Investment's NVCR Position: Q2 2026 in Review

Trexquant Investment opened a new position in NovoCure (NVCR) in Q2 2026: 166,278 shares worth $2.52M. The stake represents 0.01% of the portfolio and ranks #1094 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in NVCR as recently as Q3 2025.

Trexquant Investment first reported a position in NVCR in Q3 2017 and has held it in 21 quarters since. The position peaked at $4.35M in Q1 2024. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Trexquant Investment held 166,278 shares of NovoCure worth $2.52M as of Q2 2026.
  • NovoCure was a new Trexquant Investment position in Q2 2026.
  • NovoCure made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1094 holding.
  • Trexquant Investment first reported a position in NovoCure in Q3 2017 and has held it in 21 quarters since.
  • Trexquant Investment's NovoCure position peaked at $4.35M in Q1 2024.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.